naringenin has been researched along with Joint Pain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, YP; Jin, Y; Khanna, R; Lai, WD; Moutal, A; Park, KD; Shan, ZM; Wang, S; Wen, CP; Wu, XQ; Xu, ZH; Yu, J | 1 |
| An, N; Guo, L; Hao, RH; Luo, L; Tian, FD; Wang, B; Wang, CC; Zhou, ZH | 1 |
2 other study(ies) available for naringenin and Joint Pain
| Article | Year |
|---|---|
Neuronal CRMP2 phosphorylation inhibition by the flavonoid, naringenin, contributes to the reversal of spinal sensitization and arthritic pain improvement.
Topics: Analgesics; Animals; Arthralgia; Arthritis, Experimental; Arthritis, Rheumatoid; Chronic Pain; Flavonoids; Phosphorylation; Rats | 2022 |
Naringenin regulates production of matrix metalloproteinases in the knee-joint and primary cultured articular chondrocytes and alleviates pain in rat osteoarthritis model.
Topics: Animals; Anti-Inflammatory Agents; Arthralgia; Blotting, Western; Cell Proliferation; Cells, Cultured; Chondrocytes; Disease Models, Animal; Flavanones; Gene Expression; Interleukin-1beta; Knee Joint; Male; Matrix Metalloproteinase 3; NF-kappa B; NF-KappaB Inhibitor alpha; Osteoarthritis, Knee; Random Allocation; Rats, Wistar; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Treatment Outcome | 2017 |